deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04628702

Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia (M-AAL)

Sponsor: AustriaN Red Cross (OeRK)

Interventions tablet training
Updated 6 times since 2020 Last updated: Jul 2, 2024 Started: Feb 18, 2020 Primary completion: Jul 1, 2022 Completion: Jan 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04628702, this NA trial focuses on Alzheimer Disease and remains completed. Sponsored by AustriaN Red Cross (OeRK), it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotUnknown Status~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotUnknown~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Aug 2024 — Sep 2024 [monthly]

    Completed NA

    Status: UnknownCompleted

  3. Jul 2024 — Aug 2024 [monthly]

    Unknown NA

    Status: Unknown StatusUnknown

  4. Dec 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  5. Jan 2021 — Dec 2022 [monthly]

    Recruiting NA

Show 1 earlier version
  1. Dec 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AustriaN Red Cross (OeRK)
  • Joanneum Research Forschungsgesellschaft mbH
  • Medical University of Graz
  • health system intelligence (HS & I)
Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations